Junwei Wu

Shanghai Key Laboratory Of Gastric Neoplasms
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

GLUT3 drives paclitaxel resistance in peritoneal metastatic gastric cancer by promoting H3K18 lactylation-mediated MAPKAP1 transcription to suppress ferroptosis.

GLUT3 drives paclitaxel resistance in peritoneal metastatic gastric cancer by promoting H3K18 lactylation-mediated MAPKAP1 transcription to suppress ferroptosis.

Journal: International journal of biological sciences

Published: December 16, 2025

A multicenter, observational study to evaluate the safety of restarting antitumor therapy recovered from COVID-19.

A multicenter, observational study to evaluate the safety of restarting antitumor therapy recovered from COVID-19.

Journal: Future oncology (London, England)

Published: December 03, 2025

The Role of NADPH Oxidase 4 in Neutrophil-Mediated Immune Escape in Gastric Cancer.

The Role of NADPH Oxidase 4 in Neutrophil-Mediated Immune Escape in Gastric Cancer.

Journal: International journal of biological sciences

Published: July 18, 2025

Lenvatinib Plus Paclitaxel as Second-Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study.

Lenvatinib Plus Paclitaxel as Second-Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 12, 2025

A multidimensional recommendation framework for identifying biological targets to aid the diagnosis and treatment of liver metastasis in patients with colorectal cancer.

A multidimensional recommendation framework for identifying biological targets to aid the diagnosis and treatment of liver metastasis in patients with colorectal cancer.

Journal: Molecular cancer

Published: August 21, 2024

Lipid metabolism associated with efficacy of metronomic capecitabine and camrelizumab in gastrointestinal cancer: an exploratory clinical trial.

Lipid metabolism associated with efficacy of metronomic capecitabine and camrelizumab in gastrointestinal cancer: an exploratory clinical trial.

Journal: BMC medicine

Published: June 21, 2024

CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib.

CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib.

Journal: Molecular cancer

Published: October 09, 2023

Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial.

Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial.

Journal: Oncology letters

Published: September 25, 2023

Plasma Exosome Proteins ILK1 and CD14 Correlated with Organ-Specific Metastasis in Advanced Gastric Cancer Patients.

Plasma Exosome Proteins ILK1 and CD14 Correlated with Organ-Specific Metastasis in Advanced Gastric Cancer Patients.

Journal: Cancers

Published: July 04, 2023

Paracrine activin B-NF-κB signaling shapes an inflammatory tumor microenvironment in gastric cancer via fibroblast reprogramming.

Paracrine activin B-NF-κB signaling shapes an inflammatory tumor microenvironment in gastric cancer via fibroblast reprogramming.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 21, 2023

Eight gene mutation-based polygenic hazard score as a potential predictor for immune checkpoint inhibitor therapy outcome in metastatic melanoma.

Eight gene mutation-based polygenic hazard score as a potential predictor for immune checkpoint inhibitor therapy outcome in metastatic melanoma.

Journal: Frontiers in molecular biosciences

Published: July 24, 2022

Camrelizumab and metronomic capecitabine for patients with treatment-refractory solid tumors (McCREST trial).

Camrelizumab and metronomic capecitabine for patients with treatment-refractory solid tumors (McCREST trial).

Journal: Future oncology (London, England)

Published: June 15, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026